Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
about
Pharmacogenetics of human ABC transporter ABCC11: new insights into apocrine gland growth and metabolite secretionLocalization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico modelsArylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryInsights into CYP2B6-mediated drug-drug interactionsRNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibitionA novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinomaHuman pregnane X receptor is expressed in breast carcinomas, potential heterodimers formation between hPXR and RXR-alphaA gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.Hydroxysteroid sulfotransferase SULT2B1b promotes hepatocellular carcinoma cells proliferation in vitro and in vivo.Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancerHuman cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization.Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failureFunctional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1Overexpression of SULT2B1b is an independent prognostic indicator and promotes cell growth and invasion in colorectal carcinomaGlucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoterThe role of cytochromes p450 and aldo-keto reductases in prognosis of breast carcinoma patientsFunctional analysis of the human N-acetyltransferase 1 major promoter: quantitation of tissue expression and identification of critical sequence elements.Congenic rats with higher arylamine N-acetyltransferase 2 activity exhibit greater carcinogen-induced mammary tumor susceptibility independent of carcinogen metabolism.Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism.Mouse arylamine N-acetyltransferase 2 (Nat2) expression during embryogenesis: a potential marker for the developing neuroendocrine system.A novel gene expression signature for bone metastasis in breast carcinomas.Phase two steroid metabolism and its roles in breast and prostate cancer patientsUpdate on the pharmacogenetics of NATs: structural considerations.Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.Toxicogenetic profile and cancer risk in Lebanese.DNA Methylation of ADME Genes.Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.The earwax-associated SNP c.538G>A (G180R) in ABCC11 is not associated with breast cancer risk in Europeans.Overexpression of flavin-containing monooxygenase 5 predicts poor prognosis in patients with colorectal cancer.Robust microarray meta-analysis identifies differentially expressed genes for clinical prediction.Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
P2860
Q21131244-63F837D1-3143-4823-B91E-5F32DB7CC9ADQ21256435-6CC8574F-CD30-49B4-B45C-BB1F68FD61A2Q26995125-CC7EE085-0C43-4D7F-B297-60BDF0507AC0Q28078857-FDFE72BA-A337-42B8-9309-BE8E664C3F4CQ28477123-037FE307-A583-4657-B3D0-C05265D6817DQ28535117-D543B686-AC74-41CD-BF71-B43DADA7406EQ33329272-DC5F3712-8661-4468-B139-8A10CA512DB8Q33345012-B35A8EBA-AC24-4665-9940-C34D259A1F58Q34029272-F054F687-8469-4E6B-933A-59507B549F87Q34674259-9D049F8C-D294-45B1-BC35-A4C783BEA1CAQ35189523-BD73A712-DC15-4AF2-AA32-E106B05DBBEFQ35677128-103E0BBD-9636-4A69-B30F-51A89727FA25Q35871996-156E326F-F3D0-40DC-8DA2-E67BB0F68A7CQ35956690-91A7E181-B469-49A7-8CC4-5E29DF1A1EBCQ36021957-5BAD51CF-3DEA-4541-B432-0091946B26DFQ36065578-CEC3C591-7304-41AE-962C-5340FDF49516Q36154045-EA467B1A-CC6F-4184-8189-B0505BF9A806Q36158490-99B39404-5BF3-4CEC-BEE0-40EC30A32F20Q36328678-30FDBB3A-109E-4B65-B559-D89ACD424D85Q36393217-9216AFC3-AAEC-4BB2-AB19-535A884770B8Q36563059-AE8CD3D3-4A84-4800-A855-DBE86071B255Q36726842-BB6FC6F0-23E8-4644-9AA1-B703B55958DCQ36761684-55E0AE4E-0338-4AC3-94CA-AA8CE2B321DDQ37142561-DB641275-701D-468E-A49B-6F894192CB3DQ37329162-FE525BEA-D1F9-424B-B7C6-04364F85D0D9Q37496632-38D61D25-2677-4FB4-AEB7-7B3EDE542A1DQ38195853-72F1EC1E-7482-446B-99A0-CFDE0AFD25C6Q38802927-9045CF78-3F82-4E03-8A5C-2EE35F71E51DQ41135362-21BD3142-D8B5-4E52-BC50-8A1EC3E934EFQ46422014-8247078D-B710-4F74-A5FC-07F5DD6BFE35Q49874808-7723A168-8997-4C6B-80CF-6A38D3AF577BQ51272263-0586E520-8CE5-49D5-82A8-F1F30FE43812Q55503255-6A20E324-9AE6-422D-AAC9-93CE1DBD9401
P2860
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Relationship between intratumo ...... ostmenopausal breast carcinoma
@ast
Relationship between intratumo ...... ostmenopausal breast carcinoma
@en
Relationship between intratumo ...... ostmenopausal breast carcinoma
@nl
type
label
Relationship between intratumo ...... ostmenopausal breast carcinoma
@ast
Relationship between intratumo ...... ostmenopausal breast carcinoma
@en
Relationship between intratumo ...... ostmenopausal breast carcinoma
@nl
prefLabel
Relationship between intratumo ...... ostmenopausal breast carcinoma
@ast
Relationship between intratumo ...... ostmenopausal breast carcinoma
@en
Relationship between intratumo ...... ostmenopausal breast carcinoma
@nl
P2093
P2860
P3181
P356
P1476
Relationship between intratumo ...... ostmenopausal breast carcinoma
@en
P2093
Estelle Urbain
Igor Girault
Sengül Tozlu
P2860
P2888
P304
P3181
P356
10.1186/BCR784
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1012405217